AUD1.77
5.87% today
Australia, Apr 04, 07:10 am CET
ISIN
AU000000MSB8
Symbol
MSB
Sector
Industry

Mesoblast Target price 2025 - Analyst rating & recommendation

Mesoblast Classifications & Recommendation:

Buy
100%

Mesoblast Price Target

Target Price AUD4.03
Price AUD1.77
Potential
Number of Estimates 5
5 Analysts have issued a price target Mesoblast 2026 . The average Mesoblast target price is AUD4.03. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 6 analysts: 6 Analysts recommend Mesoblast to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Mesoblast stock has an average upside potential 2026 of . Most analysts recommend the Mesoblast stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Jun '24 2025
Estimates
Revenue Million AUD 9.01 31.91
19.19% 254.14%
EBITDA Margin -917.43% -218.49%
0.17% 76.18%
Net Margin -1,790.69% -444.60%
8.28% 75.17%

6 Analysts have issued a sales forecast Mesoblast 2025 . The average Mesoblast sales estimate is

AUD31.9m
Unlock
. This is
271.46% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
AUD48.9m 469.05%
Unlock
, the lowest is
AUD20.2m 134.64%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 AUD9.0m 19.19%
2025
AUD31.9m 254.14%
Unlock
2026
AUD142m 343.51%
Unlock
2027
AUD439m 210.51%
Unlock
2028
AUD1.1b 139.40%
Unlock
2029
AUD957m 9.00%
Unlock

3 Analysts have issued an Mesoblast EBITDA forecast 2025. The average Mesoblast EBITDA estimate is

AUD-69.7m
Unlock
. This is
3.16% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
AUD-31.5m 56.20%
Unlock
, the lowest is
AUD-130m 80.79%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 AUD-82.7m 19.06%
2025
AUD-69.7m 15.66%
Unlock
2026
AUD2.0m 102.92%
Unlock
2027
AUD-33.4m 1,739.50%
Unlock
2028
AUD-242m 623.76%
Unlock

EBITDA Margin

2024 -917.43% 0.17%
2025
-218.49% 76.18%
Unlock
2026
1.44% 100.66%
Unlock
2027
-7.60% 627.78%
Unlock
2028
-22.99% 202.50%
Unlock

3 Mesoblast Analysts have issued a net profit forecast 2025. The average Mesoblast net profit estimate is

AUD-142m
Unlock
. This is
12.07% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
AUD-106m 34.34%
Unlock
, the lowest is
AUD-183m 13.21%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 AUD-161m 12.50%
2025
AUD-142m 12.07%
Unlock
2026
AUD-36.5m 74.25%
Unlock
2027
AUD144m 494.25%
Unlock
2028
AUD89.0m 38.20%
Unlock
2029
AUD466m 423.35%
Unlock

Net Margin

2024 -1,790.69% 8.28%
2025
-444.60% 75.17%
Unlock
2026
-25.81% 94.19%
Unlock
2027
32.78% 227.01%
Unlock
2028
8.46% 74.19%
Unlock
2029
48.66% 475.18%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Jun '24 2025
Estimates
Earnings Per Share AUD -0.14 -0.12
12.50% 14.29%
P/E negative
EV/Sales 79.02

3 Analysts have issued a Mesoblast forecast for earnings per share. The average Mesoblast EPS is

AUD-0.12
Unlock
. This is
14.29% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
AUD-0.09 35.71%
Unlock
, the lowest is
AUD-0.16 14.29%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 AUD-0.14 12.50%
2025
AUD-0.12 14.29%
Unlock
2026
AUD-0.03 75.00%
Unlock
2027
AUD0.12 500.00%
Unlock
2028
AUD0.08 33.33%
Unlock
2029
AUD0.40 400.00%
Unlock

P/E ratio

Current -13.31 280.29%
2025
-15.23 14.43%
Unlock
2026
-59.15 288.38%
Unlock
2027
15.00 125.36%
Unlock
2028
24.28 61.87%
Unlock
2029
4.64 80.89%
Unlock

Based on analysts' sales estimates for 2025, the Mesoblast stock is valued at an EV/Sales of

79.02
Unlock
and an P/S ratio of
74.57
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 293.54 383.27%
2025
79.02 73.08%
Unlock
2026
17.82 77.45%
Unlock
2027
5.74 67.80%
Unlock
2028
2.40 58.23%
Unlock
2029
2.63 9.90%
Unlock

P/S ratio

Current 276.98 402.99%
2025
74.57 73.08%
Unlock
2026
16.81 77.45%
Unlock
2027
5.41 67.80%
Unlock
2028
2.26 58.23%
Unlock
2029
2.49 9.90%
Unlock

Current Mesoblast Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
PIPER SANDLER COMPANIES
Locked
Locked
Locked Dec 19 2024
MAXIM GROUP
Locked
Locked
Locked Dec 18 2024
BELL POTTER SECURITIES
Locked
Locked
Locked Aug 28 2024
Analyst Rating Date
Locked
PIPER SANDLER COMPANIES:
Locked
Locked
Dec 19 2024
Locked
MAXIM GROUP:
Locked
Locked
Dec 18 2024
Locked
BELL POTTER SECURITIES:
Locked
Locked
Aug 28 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today